—Mkt Cap: —P/E: —
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, …
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap—
Enterprise Value54.24B $
Revenue (TTM)331.19B $
Gross Profit177.26B $
Net Income (TTM)42.85B $
Revenue/Share66.41 USD
Last Price—
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees27.5K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS2561352038
Valuation
P/E (Trailing)—
P/E (Forward)18.63
PEG1.61
EV/EBITDA0.99
EV/Revenue0.16
P/S0.03
P/B15.09
EPS (TTM)0.42
EPS (Forward)0.65
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin52.77%
Oper. Margin4.25%
EBITDA Margin16.51%
Profit Margin12.76%
ROE11.36%
ROA7.40%
Growth
Revenue Growth-5.60%
Earnings Growth-68.70%
Cash Flow & Leverage
Operating CF56.76B $
CapEx (TTM)38.42B $
FCF Margin-1.18%
FCF Yield—
Net Debt-9.47B $
Net Debt/EBITDA-0.17
Balance Sheet
Debt/Equity0.21
Current Ratio1.90
Quick Ratio1.16
Book Value/Sh0.8023 USD
Cash/Share16.32 USD
Dividends
Fwd Div Rate0.0800 USD
Trail. Div Rate8.000 USD
Div. Yield0.69%
5Y Avg Yield0.72%
Payout Ratio20.19%
Ex-Div DateJul 9, 2026
Pay DateAug 5, 2026
Splits
Last Split5:1
Split DateNov 5, 2024
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.44 USD
Target Range11.36 USD – 15.73 USD
# Analysts5
Ownership
Shares Out.833.00M
Float3.59B
Insiders0.00%
Institutions15.86%
Short Interest
Short Ratio7.0d
Short % Float3.05%
Short % Out.2.51%
Shares Short20.89M
Short (prev mo.)23.19M
Technical
SMA 5012.99 USD
SMA 20013.55 USD
Beta0.24
S&P 52W Chg21.00%
Avg Vol (30d)—
Avg Vol (10d)2.51M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—